Project Grant R25CA314622
Award Date 8/10/26
Completion Date 7/31/31
Dollars Obligated $270K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Irwindale, CA 91010, USA
Similar Awards
- The National Cancer Institute awarded the Beckman Research Institute of the City of Hope $162,000 on August 11, 2026, under the Cancer Research Manpower program (CFDA 93.398) to develop and pilot a self-directed e-learning delivery model for clinical cancer genomics education. The recipient will convert selected core recorded didactic modules from its established Intensive Course in Clinical Cancer Genomics into a self-directed e-learning course bundle using theoretically grounded...
- The National Cancer Institute awarded the University of Southern California $254,091 on September 1, 2026, under the Cancer Research Manpower program (CFDA 93.398) to support postdoctoral training in integrative cancer epidemiology. The award funds a joint training program administered by USC's Norris Comprehensive Cancer Center and the University of Hawaii Cancer Center. The program trains postdoctoral fellows for independent careers in integrative cancer epidemiology research, emphasizing...
- The National Cancer Institute of the Department of Health and Human Services awarded the Beckman Research Institute of the City of Hope $733,864 on June 1, 2026, under the Cancer Biology Research program (CFDA 93.396) to identify and characterize stimulatory immune checkpoints regulating macrophage-mediated programmed cell removal in tumor immunosurveillance. The research uses high-throughput CRISPR-based screening to investigate how a novel stimulatory innate immune checkpoint interacts with...
- The National Cancer Institute awarded Virginia Commonwealth University $129,194 on August 11, 2026, under the Cancer Treatment Research program (CFDA 93.395) to expand participation in National Cancer Institute-sponsored clinical trials through leadership development, education, and community partnerships. Keri R. Maher, DO, Medical Director of the Clinical Trials Office at Massey Comprehensive Cancer Center within VCU, will dedicate 25 percent effort to this work. She will implement a formal...
- The National Cancer Institute awarded the Beckman Research Institute of The City of Hope $280,931 on August 17, 2026, under the Cancer Research Manpower program (CFDA 93.398) to support investigator-initiated research on skeletal muscle health and impaired glucose tolerance in adolescent and young adult hematopoietic cell transplantation survivors. The award funds research examining how HCT-related exposures—including total body irradiation, corticosteroid exposure, graft-versus-host disease,...
- The National Cancer Institute awarded $194,909 to the University of Florida on September 1, 2026, under the Cancer Research Manpower program (CFDA 93.398) to develop and deliver the T-CAT (Trainees Communicating About Trials) Program, which trains physician trainees to communicate with patients about cancer clinical trials across the cancer continuum. The program addresses documented barriers to cancer clinical trial accrual, which remains at approximately 7–8 percent of cancer patients, with...
- The National Cancer Institute awarded $694,015 to the Beckman Research Institute of the City of Hope on July 1, 2026, under the Cancer Biology Research program (CFDA 93.396) to identify and target cancer immune evasion signals against macrophage surveillance. The research investigates mechanisms by which cancer cells evade immune detection, with focus on tumor-associated macrophages and their capacity to recognize and eliminate cancer cells through programmed cell removal. The project...
- The National Cancer Institute awarded The Trustees of Columbia University in the City of New York $187,037 on September 1, 2026, under the Cancer Treatment Research program (CFDA 93.395) to support adolescent and young adult enrollment in oncology clinical trials through bridging national and local trial systems. Dr. Justine Kahn, an associate professor of pediatrics and clinical trialist at Columbia University Irving Medical Center and the Herbert Irving Comprehensive Cancer Center (an...
- The National Cancer Institute awarded the University of Southern California $162,501 on May 1, 2026, under the Cancer Research Manpower program (CFDA 93.398) to support methodological training for social and behavioral research in cancer control. The award funds a T32 training program that will provide six predoctoral trainees per year with innovative methodological training focused on social and behavioral cancer control and prevention research. The program applies novel study design,...
- The National Cancer Institute awarded Beckman Research Institute of the City of Hope $736,457 under the Cancer Treatment Research program (CFDA 93.395) on June 26, 2026, to develop small-molecule inhibitors targeting protein-protein interactions within the ERKS axis (comprising EphrinB, RGS3, KIF20A, and SEPT7) as a differentiation therapy for malignant brain tumors, particularly glioblastomas. The research employs a protein-protein interaction-based high-throughput screening assay to isolate...